Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The hypothesis of the study is to evaluate whether ascorbic acid is able to clear totally implanted central venous catheter
Totally implanted catheter is often occluded and thrombolytic drugs are usually used to restore permeability. In Brazil, the ascorbic acid has been used successfully by a service specialist in cancer treatment. However, no literature on international research that evaluates the efficacy and safety of this procedure. That was why it was decided to develop this research.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group 50 mg ascorbic acid | Experimental | this arm received a dose of 50 mg of ascorbic acid administered inside the catheter and maintained for up to 60 minutes |
|
| group 100mg ascorbic acid | Experimental | this arm received a dose of 100 mg of ascorbic acid administered inside the catheter and maintained for up to 60 minutes |
|
| group 200mg ascorbic acid | Experimental | this arm received a dose of 200 mg of ascorbic acid administered inside the catheter and maintained for up to 60 minutes |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ascorbic Acid | Drug | comparing three different doses of ascorbic acid: 50 mg, 100 mg and 200 mg administered inside the catheter and maintained for up to 60 minutes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Restore patency | the ascorbic acid is administered and remains inside the catheter within 60 minutes. The recovery of permeability is checked every 15 minutes until the maximum of 60 minutes | 60 minutes after administration of ascorbic acid |
| Measure | Description | Time Frame |
|---|---|---|
| Eosinophil count | the count of eosinophils was determined by collecting blood sample immediately prior to administration of ascorbic acid and 24 hours after | within 24 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christiane I Vasques, Doc | University of São Paulo, College of Nursing at Ribeirão Preto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinical Hospital of Medicine College of Ribeirão Preto, University of São Paulo | Ribeirão Preto | São Paulo | 14048-900 | Brazil |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Mar 12, 2013 | |
| Reset | Apr 23, 2013 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Mar 12, 2013 | Apr 23, 2013 |
| ID | Term |
|---|---|
| D001205 | Ascorbic Acid |
| ID | Term |
|---|---|
| D013400 | Sugar Acids |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D006880 |
| Hydroxy Acids |
| D002241 | Carbohydrates |